Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...

Patch Clamp

Patch Clamp

Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Immune system evaluation of Echinacea Purpurea root extract in female Harlan Sprague Dawley (Hsd:Sprague Dawley SD) rats.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2026

Same author

Comparative investigation of the potential of glyphosate and glyphosate-based formulations to cause oxidative stress and DNA damage in human skin and liver cell systems.

Toxicological sciences : an official journal of the Society of Toxicology·2026

Same author

Power calculations for larval zebrafish in light-dark transition test for developmental neurotoxicity.

Neurotoxicology·2025

Same author

Assessing replicability and power estimates of behavioral performance of control rats across standardized pre-clinical and toxicology studies.

Neurotoxicology and teratology·2025

Same author

Developmental immunotoxicity study of tris(chloropropyl) phosphate in Hsd:Sprague Dawley SD rats exposed through dosed feed.

Toxicological sciences : an official journal of the Society of Toxicology·2025

Same author

Statistical Analysis of Rodent Body Weight Data is Robust to Departures from Normality in Historical National Toxicology Program Studies Dated 1980-2013.

Journal of young investigators·2024

Same journal

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Drug discovery today·2026

Same journal

Organoid-AI platforms need integrated governance in drug discovery.

Drug discovery today·2026

Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026

Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026

Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026

Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 20, 2026

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Quantitative high-throughput screening data analysis: challenges and recent advances.

Keith R Shockley¹

¹Biostatistics and Computational Biology Branch, The National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.

Drug Discovery Today

|December 3, 2014

Summary

This summary is machine-generated.

High-throughput screening (HTS) advances drug discovery but faces statistical challenges in nonlinear modeling. Optimal study designs are crucial for accurate parameter estimation in quantitative HTS to improve chemical genomics and toxicity testing.

More Related Videos

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

Related Experiment Videos

Last Updated: Apr 20, 2026

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

Area of Science:

Pharmacology and Toxicology
Computational Chemistry
Biostatistics

Background:

In vitro high-throughput screening (HTS) is vital for drug discovery and toxicity testing.
Quantitative HTS generates concentration-response data for numerous compounds.
Standard statistical models face challenges with nonlinear concentration-response data.

Purpose of the Study:

To address statistical challenges in nonlinear modeling of quantitative HTS data.
To improve parameter estimation accuracy for concentration-response profiles.
To enhance the reliability of chemical genomics and toxicity testing efforts.

Main Methods:

Analysis of statistical challenges in nonlinear modeling of concentration-response data.
Evaluation of parameter estimate uncertainty in the Hill equation model.
Exploration of optimal study designs for nonlinear parameter estimation.

Main Results:

Standard designs for nonlinear models, like the Hill equation, can yield high parameter estimate uncertainty.
Inadequate consideration of standard errors hinders reliable chemical genomics and toxicity assessments.
The need for improved nonlinear parameter estimation in quantitative HTS is highlighted.

Conclusions:

Optimal study designs are necessary to enhance nonlinear parameter estimation in HTS.
Alternative approaches with robust performance characteristics may be required.
Improved statistical methods are essential for advancing drug discovery and toxicity testing.